TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4,50
arrow_upward
+1,81%(+0,080) 1D
17 nov, 11:18:35 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 4,44
Hoog
US$ 4,56
Laag
US$ 4,37
Beursw.
295,02 mln.
Gem. vol.
305,25K
Volume
102,59K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 4,44
Hoog
US$ 4,56
Laag
US$ 4,37
Beursw.
295,02 mln.
Gem. vol.
305,25K
Volume
102,59K
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
ChartMill
·
47 minuten geleden
S&P 500 Stocks Gapping Down in Today's Session
TradingView
·
1 uur geleden
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
qz.com
·
4 uur geleden
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc